Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3060 participants.

Also called NCT07388030

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 3,060 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07388030
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07388030. Randomized; single masking; primary purpose treatment. Start 2026-03-20 (anticipated); primary completion 2030-01-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION
Acronym
LOCATION
Condition
Severe Coronary Artery Disease
Condition
Coronary Artery Calcification
Intervention (Device)
IVL Pretreatment + OCT-Guided Stent Implantation
Intervention (Device)
IVL Pretreatment + Angiography-Guided Stent Implantation
Intervention (Device)
Balloon Angioplasty (BA) Pretreatment + OCT-Guided Stent Implantation
Intervention (Device)
Balloon Angioplasty (BA) Pretreatment + Angiography-Guided Stent Implantation
Lead sponsor
Shanghai Bluesail Boyuan Medical Technology Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07388030
Content hash
609fe96d019447794fe05d52458c6944dd5149dccfea7c764897b839fdd8d7f0